Minireviews
Copyright ©The Author(s) 2015.
World J Ophthalmol. Aug 12, 2015; 5(3): 125-132
Published online Aug 12, 2015. doi: 10.5318/wjo.v5.i3.125
Table 1 Summary of some intravitreal agents
ApplicationDuration of actionVisual acuityGlaucoma surgeryCataract surgery
IVTA 4 mg (kenalog)Injection3-7 mo[17]58.3% gained ≥ 2 Snellen lines with a median 40.5-mo follow-up[16]1%-2%[10]15%-30%[10]
FA 0.59 mg (retisert)Surgical implant30 mo[21]23% gained ≥ 3 lines after 3 yr[21]32%-40%[21,23,25]Nearly 100%[21,23,25]
Dexamethasone 0.7 mg (ozurdex)Non-surgical implant4-6 mo[21]38% gained ≥ 3 lines at 6th month[29]None[30]1.3%[30]
MTX 400 μgInjection4 mo[21]38% gained ≥ 2 lines at 3rd month[21]None[21]None[21]